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ABSTRACT 
 
Deciphering the Effect of Nemaline-Myopathy Nebulin Mutations on Desmin Binding. 
(April 2010) 
 
Krystyna Marie Jacobs 
Department of Biomedical Science 
Texas A&M University 
 
Research Advisor: Dr. Gloria M. Conover 
Department of Veterinary Pathobiology 
 
Our research focuses on the role of intermediate proteins in human disease.  Desmin, a 
major intermediate filament protein in muscle cells, is organized into a central coiled-
coil alpha helical domain flanked by globular head and tail domains. Our goal is to 
decipher the functional significance of the association of desmin to the giant thin 
filament protein nebulin at the sarcomeric Z-discs and its relation to muscle disease. 
Mutations in nebulin cause nemaline myopathy, a debilitating genetic muscle disease 
that affects children and adults alike.  Previous research has shown that nebulin has a 
high affinity binding to desmin.  However, little is known about the contribution of 
lower affinity binding desmin domains to nebulin or about the involvement of this 
interaction in nemaline myopathy.  We hypothesize that the desmin 3-dimensional 
linkage to nebulin contributes to nemaline myopathy pathology.  To test our hypothesis, 
we tested the binding profile of a nebulin-associated nemaline myopathy mutation to 
particular desmin domains using biochemical approaches.  Our ELISA and GST-pull 
down assays showed that nebulin modules 160-164 bind to desmin’s central rod coil 2b 
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and tail subdomains.  Moreover, we found significantly decreased binding of the desmin 
coil 2b to the nemaline myopathy Nebulin M160-164 T5681P mutant as compared to 
nebulin M160-164.  A 3-fold binding increase of the coil 2b was found in random 
alanine nebulin M160-164 L5646A mutant as compared to nebulin nemaline-associated 
nebulin M160-164 T5681P mutant, underscoring the importance of this region to the 
interaction of desmin and nebulin. Taken together, our findings suggest that differences 
in the binding profile of nemaline-associated nebulin mutations to desmin may 
contribute to our understanding the underlying molecular mechanism responsible for this 
disease.  This knowledge may be significant because it may aid in devising new 
treatments for nemaline myopathy patients in the future.  
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NOMENCLATURE 
 
NM Nemaline myopathy 
IF Intermediate filaments 
WT Wild-type protein 
Min Minutes 
H Hours 
RT Room temperature (25ºC) 
ON Overnight incubation 
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The cytoskeleton of a cell is composed of fibrillar three major cytoplasmic elements. 
These fibrillar elements are intermediate filaments (IFs), microfilaments (MFs), and 
microtubules (MTs). Our research focus is on the main intermediate filament muscle 
protein, desmin, its linkage to the contractile apparatus, and its contribution to muscle 
disease.  IF proteins are grouped into six types (I-VI); types I-IV are found in the 
cytoplasm, type V is found in the nucleus and type VI is found in the lens of the eye. 
Desmin is a type III IF protein and mutations in desmin are known to cause debilitating 
cardiomyopathies and skeletal myopathies. (Omary, 2009). IFs are important for cell 
function because they create the backbone of the cell acting as major mechanosensors 
and mechanotransducers for various cell processes including cell migration, respiration 
and organelle trafficking (Reviewed in Herrmann et al., 2007).  
Remarkably, in the last 20 years, over 80 human diseases have been associated with 
mutations in IFs.  For example, keratin 14 was the first IF to be associated with a human 
disease called Epidermolysis bullosa simplex. From this discovery, scientists realized 
that there are a large amount of Mendelian-inherited diseases caused by mutations in 
genes that encode IF-proteins (Omary, 2009).  
_______________ 
This thesis follows the style of Molecular Biology of the Cell. 
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Our research focuses on the contribution of the desmin linkage to the contractile 
apparatus and how this may relate to disease states such as nemaline myopathy (NM). 
Nemaline myopathy is caused by inherited mutations in muscle proteins; nebulin, 
tropomyosin, actin, troponin and cofilin (Reviewed in Sanoudou and Beggs, 2001).  It is 
a non-progressive disease of the voluntary muscles, caused in most cases by mutations in 
the actin-binding thin filament protein nebulin NEM 2.  Clinical phenotypes are highly 
heterogeneous; and patients exhibit different ages of onset and severity. Though the 
clinical signs are variable, there are some that are common to all nemaline myopathies. 
These are moderate to severe weakness in leg, arm and trunk muscles; mild to moderate 
weakness of the face, tongue and throat muscles; the reflexes are decreased or absent; 
high-arched feet, curvature of the spine and jaw malformation may also be observed. 
The worse form of NM appears at birth, children will have marked weakness and lack of 
muscle tone, and death will occur in the first few years due to respiratory failure.  
 
Anatomy of the sarcomere 
There are two major systems that help the sarcomere contract and relax. These are the 
thin and thick filament systems; actin and myosin are the major proteins that constitute 
the framework of this minimal contractile unit. Myosin is a thick filament associated 
with the center of the sarcomere; its main function is to interact with actin and utilize 
energy from ATP hydrolysis to generate mechanical force (contractions). Actin is part of 
the thin filament system; it is intertwined with nebulin and acts as the scaffold on which 
myosin can generate force for contractions in the sarcomere. Desmin is an intermediate 
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filament that has a mix of alpha-helical and non-helical structures. These three elements, 
thin, thick and intermediate filaments, bind together to create the cytoskeleton that each 
contractile cell relies on to generate force. Mutations in any region of this network can 
cause mild to severe myopathies. Desmin and nebulin myopathies and the mutations that 
cause them are the focus of our research. 
 
Desmin structure and muscle disease  
Desmin was discovered in the early 1970’s (Lazarides and Hubbard, 1976). It is 
expressed in cardiac, skeletal and smooth muscle. It connects with other proteins in the 
cell to create a continuous cytoskeletal network that maintains a spatial relationship with 
the contractile apparatus and other structural elements. This helps the cell to maintain its 
cellular integrity (Reviewed in Goldfarb and Dalakas, 2009). Desmin is organized into 
three domains; a highly conserved α-helical core of 308 amino acid residues that is 
flanked by globular N- and C- terminal regions. The N-and C- regions are known as the 
‘head’ and ‘tail’ regions, respectively. The helical core has a seven residue (heptad) 
repeat pattern that guides two polypeptides to for a homopolymeric coiled-coil dimer. 
The heptad periodicity within the helical rod is interrupted in several places. This results 
in four helical segments known as 1A, 1B, 2A, and 2B; which are connected by 
nonhelical linkers (Reviewed in Goldfarb and Dalakas, 2009).  
Desmin IFs form a tetramer that consists of homopolymers (Reviewed in Herrmann et 
al., 2007). During assembly in the cytoplasm, desmin combines with other desmin 
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tetramers to form unit-length filaments (ULFs). These bind with other ULFs and short 
filaments to eventually form a radially compacted protein (Herrmann et al., 2009).  
Desminopathy is characterized by mutations in the protein desmin, which in some cases 
has been demonstrated to interfere with the normal filament assembly by in vitro 
assembly assays and cardiac cells (Bar et al., 2005a). 45 known disease-causing desmin 
mutations have been reported; 40 of the mutations are missense, 3 are small in-frame 
mutations, 1 is an exon-skipping mutations and 1 is an insertion that results in premature 
translation termination (Reviewed in Goldfarb and Dalakas, 2009). The disease is almost 
always characterized by increased amount of desmin within the sarcomere present as 
aggregates (Goebel, 1995). The clinical signs of desminopathy are skeletal muscle 
weakness associated with cardiac conduction blocks, arrhythmias, and restrictive heart 
failure.  
 
Nebulin family structure and muscle disease  
Nemaline myopathy (NM) is categorized as a form of congenital myopathy (Youssef et 
al., 2009).  Most of the NM cases are due to mutations in the large thin filament protein 
nebulin. Nebulin was discovered in the early 1980’s (Wang, 1981). Each of the central 
modules (M1-180) directly interacts with actin monomers contained within the thin 
filaments of muscle (Panaviene et al., 2007).  Nebulin is a 600-900 kDa giant protein 
that is localized on the actin thin filament of striated muscle. The structure of nebulin is 
highly repetitive, due to the modules that are 30-35 amino acid residues long and 
arranged into simple and super repeats. Nebulin’s central region contains 22 of these 
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super repeats; each has seven 35-residue simple repeats within them. The actin binding 
site is identified by the SDXXYK-motif, which is repeated. Nebulin has an 8-kDa N-
terminal and a 20-kDa C-terminal; both have unique protein domains. Within the C-
terminus there is a conserved src homology (SH3) domain; which may bind titin. α-actin 
anchors this terminus to the Z-disc of the muscle sarcomere. The Z-disk peripheral 
region binds desmin (Bang et al., 2002; Conover et al, 2009).  
The N-terminus of nebulin binds tropomodulin at the pointed end of the thin filament 
(McElhinny et al., 2001). Tropomodulin acts to bind and cap the pointed end of actin, 
and studies have shown that it plays a role in regulating the length of actin filaments in 
striated muscle.  In vivo research has given evidence that nebulin functions in thin 
filament regulation, helps maintain physiological Z-disc length and assists in 
myofibrillar connectivity (Tonino et al., 2010).  Recent mouse knock-out studies have 
shown than nebulin stabilizes the thin filament rather than functions as a ruler for thin 
filament length (Ottenheijm et al., 2009).  Emergent nebulin isoforms are thought to 
function in a similar fashion as nebulin in skeletal muscle. The proteins are all modular 
proteins with the defining structure being the presence of the 35-residue nebulin 
modules. The isoforms are nebulette, N-RAP, LASP-1, and LIM-nebulette (Panaviene 
and Moncman, 2007).  
 
Nebulin and nebulette: actin binding proteins 
Nebulin was identified in 1981 as a major component of skeletal muscle (Wang, 1981). 
Nebulette, identified in 1995, is a cardiac nebulin- like protein has a mass of 107 kDa 
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(Moncman and Wang, 1995). It was demonstrated that nebulette is present in extracts of 
heart tissue from a variety of species; chickens, mice and rabbits, and that this protein is 
located in the I-Z-I complex of developing cardiomyocytes and isolated myofibrils 
(Moncman and Wang, 1995).  Nebulette associates with the Z-lines of cardiac muscle 
sarcomeres. 
 Previously nebulin was thought to be a molecular ruler because it was found to extend 
the length of the thin filament (Kruger et al., 1991). Its role at a molecular ruler would 
be to specify thin filament lengths during myofibrillar assembly. Once the thin filament 
reached the same length as nebulin, it directs Tmod capping to cut the end of the thin 
filament.  Measured actin dynamics in skeletal and cardiac muscle do not follow the idea 
of nebulin as a molecular ruler. Thin filaments must be continually regulated during a 
cells life time, this supports a new hypothesis that nebulin assists in thin filament length 
regulation, not as a ruler (Reviewed in Littlefield and Fowler, 2008).  
Nebulette has a molecular mass of ~100 kDa, so it is predicted to extend 150 kDa from 
the center of the Z-line (Moncman and Wang, 1995, 2000) which makes it unlikely to 
serve as a molecular ruler for cardiac muscle (Holmes and Moncman, 2008).  
 
Similarities between nebulin and nebulette 
Nebulin and nebulette share a 70% sequence homology and have highly similar domain 
layouts. The primary structures of these two proteins were analyzed  to define the 
structurally important features in relation to the Z-line architecture (Moncman and 
Wang, 2000). They found that a partial cDNA corresponding to chicken adult nebulette 
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was found to be composed of nebulin-like 35 residue modules. Characterization of 
nebulette amino-acid sequence demonstrates that nebulette shares extensive sequence 
homology with the C-terminal portion of nebulin and also exhibits a four domain layout 
with high similarity to that of skeletal muscle nebulin (Moncman and Wang, 1999). Both 
nebulin and nebulette contain large domains composed of 35 residue modules; the motif 
is repeated 22/23 time in human nebulette and over 185 times in human nebulin 
(Moncman and Wang, 2000). In addition to the similar domains, nebulin and nebulette 
contain a linker and Src 3 homology at their C-terminal(Moncman and Wang, 2000). 




Figure 1: Domain organization of nebulin and its cardiac isoform nebulette. Nebulette reveals a four-domain 
layout similar to skeletal muscle nebulin. There is a short, acidic N-terminal, followed by 22 nebulin like repeats that 
are linked to a C-terminal Src homology 3 (SH3) via a short linker domain (Holmes and Moncman, 2008). 
 
 
Some scientists speculate that the likelihood of nebulette having the identical functions 
in cardiac muscle as nebulin in skeletal muscle is not probable due to its smaller size. 
The fact that nebulette has been shown to interact with thin filament components in 
cardiac muscle, supports the notion that it may perform have some common functions 
with nebulin (Holmes and Moncman, 2008).  
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Research focus and hypothesis 
Our research interest is the connection of desmin to the sarcomere and its effect on 
myocyte function during normal and disease.  Previous experimental findings have 
concluded that desmin binds to nebulin, and have reported that desminopathy associated 
desmin mutation E245D increases binding to nebulin and perturbs actin thin filament 
architecture (Conover et al., 2009).  This is the first example of an intermediate-protein 
associated protein (IFAP) nebulin that has a dramatic structural effect on actin thin 
filaments in a desminopathy caused by a desmin mutation.  Interestingly, this particular 
desmin mutation E245D forms seemingly normal filaments in vitro (Bar et al., 2005b), 
suggesting that the molecular defect present in this case may indeed be caused by the 
inability of the contractile apparatus to communicate with the intermediate filament 
network (Conover et al., 2009).  Together, these findings are the basis to propose our 
hypothesis for this thesis that nebulin mutations associated with nemaline myopathy, 
located in nebulin modules that are known to date to be within modules that interact with 
desmin, could result from alterations in binding of nebulin to the desmin in skeletal 
muscles. 
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CHAPTER II 
METHODS AND MATERIALS 
 
His-tag and GST-tag affinity protein purifications were performed to prepare desmin and 
nebulin proteins used in GST pull down experiments and ELISA assays. A Bradford 
assay was performed on dialyzed His-tag proteins to determine their concentrations for 
GST-pull down and ELISA assays. The concentration of the protein is needed in order to 
determine the correct molar rations for the amount of GST-beads to His-tag protein in 
the GST-pull down and the nM concentration of proteins to be used on plate and in 
solutions for ELISA assays.  
 
Bacterial protein inductions 
On day 1 the bacterial colony is added from a culture plate to 40ml of 2xYT media and 
40µl of the appropriate drug selection; Ampicillin (25ug/ml) for GST-Nebulin fragments 
and Kanamycin (50ug/ml) for His-Nebulin fragments. E. coli bacteria BL21 strain grows 
overnight in a shaker at 37oC. The next day, the overnight culture is transferred to a 
larger flask with 800ml 2xYT media and 800µl of the appropriate drug selection.  The 
culture continues growing for 90 minutes, at this time an OD600 reading is taken along 
with a 1ml gel sample. The goal is to get the reading as close as possible to 0.600, to 
ensure that the bacteria is just entering the log phase of bacterial growth. Once the OD600 
reaches this level 0.5M IPTG is added to the flask and the culture is induced for 3-4 
hours. After this time another OD600 is taken along with a 1ml gel sample. The rest of the 
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culture is spun down in a centrifuge at 5000 rpms for 10 minutes. The resulting pellet is 
frozen at -20oC until it used for affinity purification. 
 
His-tag affinity protein purification 
The His tagged nebulin fragment pellets are resuspended with 10ml lysis buffer (list 
composition) and 200µl of protease inhibitors (Sigma). After resuspension the pellets are 
homogenized 3 times each by dounce homogenization, 10 plunges each time. This 
provides a mechanical lysing of the pellets. The next step is to centrifuge the dounce 
homogenized pellets at 15000 rpms for 45 minutes to achieve a clear soluble lysate. 
While the pellets are centrifuging, Ni-NTA beads need to be rinsed to remove the EtOH 
in the storage solution. This procedure is repeated 3 times to completely clean the beads. 
400µl of Ni-NTA beads and 400µl of lysis buffer in an eppendorf that is centrifuged at 
14,000 rpms for 1 min. The clear lysate is separated from the centrifuged pellet and 
placed in a labeled 15ml conical with 400µl of clean beads. The conical are incubated 
overnight at 4oC on a tube rotator.  
The next day, batch purification of the lysate and bead mixture is performed. Disposable 
15mls columns are used for all the washes and elutions. The wash buffer (100nM 
NaH2PO4, 10nM Tris-Cl, 8M urea; pH to 6.3) is a mixture of 250ml wash buffer and 
2.5ml Triton X-100. The protein and bead mix is transferred to the disposable column 
and the flow through is collected into a clean 15ml conical, this samples constitutes the 
unbound lysate.  
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The next step is to wash the beads with 10ml wash buffer plus1% Triton X-100, 3 times. 
The flow through is collected in a separate conical after each wash. The last step is to 
elute the beads with 0.3ml of elution buffer (100nM NaH2PO4, 10mM Tris-Cl, 8m urea; 
pH to 4.5) is added to the column and 0.5ml is collected in consecutive labeled 
eppendorfs (elution 1-6). The success of the purification is evaluated by SDS-PAGE. 
Several gel samples are collected: 40µl of each elution unbound lysate, all three washes 
and a bead sample after elutions were collected; 80µl 3X lamelli buffer is added to each 
gel sample.  Samples are boiled prior to loading into the SDS-PAGE gel. To examine the 
elution gel samples 20µl each are used plus 40µl 3X lamelli buffer. The gel in figure 2 is 
an example of the elutions taken from purification. Figure 2 also has a flow chart 
illustrating the steps previously described in this section. The flow chart provides a basic 
outline for the procedure that can be modified as needed. 
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Figure 2: His-tagged purified proteins analyzed by SDS-PAGE electrophoresis. (A) Flow chart for His-tag 
purification details individual steps required for the affinity tag purification. (B) SDS-PAGE gels pictured are of His-
Nebulin 160-164 Wild type, Nebulin 160-264 T5681P and Nebulin 160-164 L5646A purification samples before and 
after dialysis into binding buffer was performed. The concentrations of each protein were determined using the OD600 
values obtained in the Bradford assay. These gel samples correspond with the concentration values I calculated. The 
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GST-tag affinity protein purification 
The pellets are resuspended with 25ml of 1X PBS/ 1% Triton X-100 plus 200µl of 
protease inhibitors (Roche). Once the pellets have been resuspended, 0.5ml of 1mg/ml 
chick embryo lysozyme is added, and then the solution sits on ice for 30 minutes. 
During this time the glutathione beads are rinsed, by adding 500µl of beads and 500µl of 
1X PBS to an eppendorf and centrifuged 14000 rpms for 1 min. The supernatant is 
discarded and 500µl of 1X PBS is added. The procedure is repeated three times to ensure 
that the beads are clean of their storage solution. After 30 min, the pellets are sonicated 3 
times each, with ten bursts each time with a 1min rest between sonication always 
keeping the samples on ice. After sonication, the samples are dounce homogenized 3 
times each, with ten plunges each time on ice. The bacterial lysate is then centrifuged at 
15,000 rpms for 45 min, and the resulting clear lysate is pipetted into a 15ml conical 
mixed with 500µl of glutathione beads. The bead and lysate mixture is rotated at 4oC for 
90 minutes.  
Once this time is done, the conical is centrifuged at 3000 rpms for 5 min and the 
supernatant is removed, this is the unbound lysate. 10mls of wash buffer (1X PBS/ 1% 
Triton) is added to the beads to remove non-specific proteins binding. The mixture is 
centrifuged at 3000 rpms for 5 min. The beads are stored at 4oC until needed for pull-
down experiments. Several gel samples are collected: 40µl post-dounce homogenized 
sample, a 40µl clear lysate sample, a 40µl wash sample and a 40µl bead sample. 80µl of 
3X lamelli buffer are added to each sample and analyzed on a SDS-PAGE gel that is 
stained with Coomassie brilliant blue to visualize the proteins. 
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Bradford assay 
The Bradford assay is used to estimate the concentration of proteins to be used 
subsequently in biochemical assays. Affinity purified proteins are dialyzed ON into 
binding buffer (80mM KCl, 20nM HEPES, 2mM MgCl2; pH to 7.4) or 1X PBS. These 
concentrations are used to determine the amounts of dialyzed protein that will be used in 
ELISA assays and pull down experiments. There are 3 controls that need to be used for 
the Bradford assay: BSA stock, dye, and binding buffer. The assay is performed by a 
series of dilutions of the target proteins and BSA standard in a 96 well microtiter plate. 
The first dilution of BSA standard is 250ug/ml, each dilution after that is one half of the 
previous dilution until 1.8ug/ml is reached. The dilutions are made by taking 500µl of 
the previous concentration and adding 500µl of binding buffer to reduce the 
concentration by one half.  
The protein dilution is different because the concentration of the protein is unknown. For 
these dilutions, 50µl of protein to 270µl of binding buffer for the first well, this is a 
dilution of 0:0. From there 160µl of the first dilution is taken out an added to 160µl 
binding buffer to create a 1:2 dilution. This step is repeated until a dilution of 1:128 is 
reached. Once all the dilutions have been performed, 160µl of each dilution is added to 
its respective well. To each well 40µl of dye is added and the plate is left at room 
temperature for at least 5 minutes but no longer than one hour. The concentration of each 
protein is measured with an Omega plate reader, which gives an absorbance level in 
OD595. From this OD595 reading, along with a standard curve graph; seen in Figure 3, 
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and the concentration of each unknown protein tested is estimated based on a linear 
regression of the BSA standard.  
 
Figure 3: Bradford assay. The standard curve shown depicts a BSA standard curve. A OD595 absorbance was used to 
calculate the concentration of each protein. In this assay, the concentration of the following fragments was estimated: 
His-nebulin 160-164 WT is 0.312ug/ml, nebulin M160-164 T5681P is 0.584ug/ml, and Nebulin 160-164 L5646A is 
0.490ug/ml. The fit of the graph represents the absorbance levels of the tested proteins at 405nm. An R-value of 0.88 . 
This value corresponds to the slope of the linear fit of the known dilutions for BSA. Triplicate well were performed 
the mutants, T5681P and L5646A; and duplicate sample were performed for the WT protein. These concentrations 
were used to plan the GST-pull down experiment. 
 
GST-pull down assays 
The GST-pull down is used to determine the capacity of GST-tagged desmin fragments 
to associate to His-nebulin protein fragments. The amount of protein used is dependent 
on the concentration of His-nebulin proteins and the estimated amount of GST-desmin 
protein present in the glutathione beads from the GST-desmin purification.  Based on 
SDS-PAGE analysis of GST-protein/bead slurry and the protein concentration of the 
nebulin fragment a determined amount of each protein is mixed in a 1.5ml tube. The 
beads are washed twice with 100ul of binding buffer (or 1x PBS)/ 0.1% Triton, and spun 
for 2 min at 3000 rpms for each wash. After the washes the His-nebulin fragment 
previously dialyzed into the appropriate buffer is added to the GST-nebulin bead/protein. 
The final volume of the eppendorf is brought to 100ul and it is incubated for one h in a 
small tube rotator at 4oC.  
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After incubation, the bead / His-nebulin mixture is washed 5 times with binding buffer 
(or 1x PBS)/ 0.1% Triton, with two min at 3000 rpms in a centrifuge for each wash. 
Once the washes are complete, 70ul of 3 X lamelli buffers is added to the beads and 
analyzed on a 15% SDS-PAGE gel. There will be control beads for each gel; these 
consist of clean glutathione beads that have gone through the pull-down process, except 
that no proteins have been added. Since the bound protein pairs will coprecipitate both 
samples, this ensures that the size of each protein is compared from the control samples.  
 
 
Figure 4: GST pull down procedure. The pull down experiment flow chart is an overview of the steps for this 
procedure. Minor adjustments to the procedure have been made depending on the starting materials, for example, the 
amount of GST-protein/bead slurry used or using 1X PBS buffer instead of binding buffer. These changes are to be 
expected since they are based on the buffer used in dialysis and purification and the concentrations of the His-nebulin 
proteins being used at the time. 
 
ELISA binding assay 
The ELISA (Enzyme-linked immunosorbent assay) plate is coated with 40nM of 
Nebulin fragment (in binding buffer 20mM Hepes pH 7.4, 80mM KCl, 2mM MgCl2) for 
GST pull down flowchart 
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endpoint ELISAs and 50nM Nebulin fragment for Saturation curves per well in 100µl 
total volume in 0.1M Carbonate buffer pH 9.6 (3.43g sodium bicarbonate + 0.97g 
sodium carbonate in 500ml H2O; pH with NaOH) and left at 4oC overnight. For each 
saturation curve ELISA control wells were also included as part of the experimental 
design. These wells were the nebulin fragment with no protein in solution only BSA in 
the buffer, recombinant GST-protein alone with BSA,d and carbonate buffer with no 
protein added on the plate or in solution.  The next day, the wells need to be washed 4 
times with binding buffer/ 0.05% Tween/ 0.5%BSA. After washing, the wells are 
blocked for 30 min with binding buffer/ 0.2% BSA/ 0.05% Tween at 4°C. After 30 min, 
100nM of biotinylated coil 2b and GST control in binding buffer/ 0.2% BSA/ 0.05% 
Tween is added to each well and incubated at RT for 1h. The wells are once again 
washed 4 times with binding buffer/ 0.05% Tween/ 0.2% BSA. Next, the wells are 
incubated with ImmunoPure Strepavidin antibodies(Pierce), diluted to 1:20000 in 
binding buffer/ 0.05% Tween/ 0.2%BSA, for one h at RT.  
After this incubation, the wells are washed 4 times with binding buffer/ 0.05% Tween/ 
0.2% BSA. Then pNPP substrate (Sigma N-9389) was added at 1mg/ml in Substrate 
buffer (0.1 M glycine, 1mM MgCl2, 1mM ZnCl2; pH to 10.4 with NaOH). The plate was 
incubated at 37°C for 30 min. The plate was read at 405nm using Omega 
spectrophotometer plate reader.  The layout of the plate is specified on the machine 
before reading. Once the absorbance values are obtained, we can plot a curve and 
estimate the affinity constant for a pair of binding proteins. Figure 5 shows the layout of 
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the ELISA plate and a graph that illustrates the binding affinity of the nebulin fragments 
to GST-alone and GST-coil 2b. 
 
Western blot analysis 
Western blots were used to detect specific proteins within a given sample. In our 
experiments, we attempted to detect His-tagged nebulin proteins.  The samples are run 
on a SDS-PAGE gel at 150V for 1 h and 30 min. The proteins in the gel are transferred 
to a nitrocellulose membrane using an electrophoretic transfer box and a methanol based 
transfer buffer (20nM Tris, 150nM Glycine, 20% Methanol).  The transfer was 
performed for 1 h at 100V or ON at 30V at 4°C. Once the transfer is completed, the 
membrane is stained with Ponceau-S stain for 5 min, then it is rinsed with distilled 
water.  The membrane is blocked in 1X PBS/ 5% milk for 1 h. The blocking step ensures 
that the antibody attaches only to the target protein by saturating unoccupied binding 
sites with BSA present in the milk. Once the blocking step is complete, the membrane 
can be probed with the desired antibody.  In our experiments, we use two different 
antibodies; a monoclonal His-HRP conjugated antibody, which binds to His-tagged 
proteins, and polyclonal rabbit nebulin M160-164 antibodies, which specifically binds to 
the 160-164 region of nebulin which are subsequently incubated with secondary anti-
Rabbit HRP antibodies.   
For the His-antibody Western blot analysis, we use 10ml of the milk and approximately 
1:2000 dilution of the antibody. This mixture is used to cover the membrane and gently 
shaken at RT for 1 h. The membrane is washed 4 times with 1X PBS/ 0.05% Tween, 
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using 10ml for each wash.  Once the washes are finished the membrane is developed. To 
do this, we place the membrane between two protector sheets in the cassette. To the 
membrane we add a mixture of 200ul SuperSignal® West Pico Stable Peroxide and 
200ul SuperSignal® West Pico Luminol/Enhancer solution, this mixture allows the film 
to pick up the fluorescent tags of the secondary HRP antibody that has bound to the 
target protein. In a dark room, the film is exposed for 1min, 10 min and ON if needed. 
Once we are finished with developing the membrane we can strip it and add a new 
antibody to detect the GST-proteins on the membrane. 
To strip the membrane of the first antibody we use 0.1M Glycine buffer pH 2.5, 1X 
PBS, and 1M NaCl in PBS. The first step is to strip the membrane at RT with 10ml 0.1M 
Glycine buffer for 15 min. Next the membrane is washed with 1X PBS for 10-15 min. 
This is followed by 1M NaCl in PBS for 15 min and another wash with 1X PBS for 10 -
15 min. After the membrane has been stripped; the normal steps for Western blotting, 
starting with blocking in 5% milk, are repeated. The new antibody uses a two step 
process. After the membrane has been blocked the primary antibody, anti- nebulin 
M160-164 rabbit antibody, was added, approximately at a 1:5000 dilution in 1X PBS/ 
5% milk, to the membrane for 1 h at RT. After the secondary antibody goat anti-rabbit 
IgG is added at 1:20000 dilution in 1X PBS/ 5% milk, the membrane is incubated for 1 h 
at RT. Finally, the washes are performed and the membrane developed in a similar 
manner as described above. 
 
 





Recent published results showed that the non-mutated WT nebulin modules 160-164 
bind with a high affinity to the coil 1b region of desmin (Conover et al., 2009).  In this 
Thesis, we used a nemaline-myopathy associated mutant -nebulin M160-164 T5681P-, 
and a control mutant in the same region -nebulin 160-164 L5646A- to investigate its 
binding properties to different regions of desmin intermediate filaments. Through GST-
pull down and ELISA assays we have determined whether these mutant proteins bind to 
desmin, to assess in future studies whether these binding interactions might result in 
architectural alterations in the overall binding of desmin intermediate filaments linkage 
to the sarcomeres by the thin filaments via nebulin. 
 
Desmin coil 2B region binds Nebulin mutant M160-164 L5646A 
It has been shown that desmin binds to nebulin module M160-164 through ELISA 
assays (Conover et al., 2009).  In this Thesis, we show that desmin coil 2b binds to WT 
nebulin M160-164 and to its L5646A mutant through GST-pull down experiments, as 
illustrated in Figure 5.  To verify these results, we used a Western blot analysis on the 
samples probed with specific anti-nebulin M160-164 antibodies. This allowed us to 
verify that the bands seen with GST-coil 2B in the gel were nebulin M160-164. The film 
is shown in Figure 5 along with the Ponceau-S staining of the same membrane.  
 





Figure 5: GST pull down experiment of His tagged nebulin fragments with GST-coil 1B and 2B along with Western 
blot analysis of the samples.  
The fragments show that both WT and mutant L5646A nebulin M160-164 are capable of binding both alpha-helical 
desmin central coil 1B and 2B fragments. (A) GST-pull down assays show that GST-coil 2b (42kDa) binds to the 
L5646A (27kDa) mutant and to GST-coil 1b domain (40kDa), the latter domain had been shown previously to bind 
very strongly to the wild type nebulin M160-164 (25 kDa).  (B) The Western blot analysis of the samples verifies that 
nebulin mutant L5646A was pull-down with GST-coil 1B and GST-coil 2B coated glutathione beads. 
 
Our GST-pull down results show that desmin’s coil 2b binds as well to WT nebulin 
M160-164 to L5646A nebulin M160-164.  ELISA assays were used to determine and 
compare the binding affinities (Kd) for the each of the nebulin fragments. Through 
ELISA assays we determined that the binding affinity of desmin coil 2b was much 
GST-Coil 2b GST-Coil 1b 
Neb 160-164 WT Neb L5646A 
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weaker toward L5646A that it was to the WT nebulin M160-164. The data consistently 
showed a decrease (~5 fold) in binding of L5646A to coil 2b as compared to WT nebulin 
M160-164 protein. The affinity constants (Kds) determined in experiment shown in 
Figure 6 are 10-fold different between the two samples.  In particular, the lower Kd 
obtained for coil 2B binding to WT nebulin M160-164 suggests a stronger binding 
affinity as compared to that of mutant nebulin M160-164 L5646A. Both biochemical 
methods consistently showed that desmin coil 2b binds to both proteins, and revealed a 
lowered binding affinity (with an estimated Kd of 175.2 nM) to the mutant nebulin 
M160-164 L5646A as compared to WT protein that had an estimated Kd of 18nM.  This 
data suggests that single missense mutations in nebulin are capable of altering the 
interaction between desmin and nebulin, which are expected to dramatically influence 
the sarcomere contractile function by decreasing the binding of the thin filaments to the 
extrasarcomeric desmin network.  
 
 
Figure 6: ELISA assay shows the saturation curve of desmin coil 2b and WT nebulin M160-164 as 
compared to desmin coil 2b and nebulin M160-164 L5646A.  The nebulin fragments were plated at a 
concentration of 50nM on the microtiter plate and tested for binding with desmin coil 2B at different concentrations. 
The graph shows that desmin coil 2b binds to nebulin M160-164 with an estimated dissociation constant (Kd ) of 
18nM and a binding capacity (Bmax) of 3.9.  In contrast, our results show that desmin coil 2b binds to the nebulin 
M160-164 L5646A mutant with a Kd of 175.2nM and a Bmax of 5.8.  




Desmin coil 2B shows decreased binding to nebulin mutant M160-164 T5681P 
The coil 2b region of human desmin spans amino acids (296-416); the tail region spans 
the region (417-470).  The full-length desmin protein is 470 amino acid residues long. 
Our results showed that the tail region of desmin binds to the nemaline-associated 
nebulin mutant T5681P (Figure 7).  Specifically, our pull-down experiment indicates 
that desmin GST-tail bound to nebulin M160-164 T5681P (data not shown).  Our 
preliminary results showed no detectable binding of nebulin M160-164 T5681P to 
desmin coil 1B region by this method, in stark contrast to the high affinity binding 
interaction known to occur between WT nebulin M160-164 and desmin coil 1B 
(Conover et al. 2009). Ongoing ELISA experiments will determine the Kd for this 
association.  
  To further characterize of the binding capacity of nebulin M160-164 T5681P as 
compared to a random alanine mutant exchange in the same region L5646A we 
performed saturation curves ELISAs on the same plate testing these mutants for binding 
for both the coil 2b and tail regions of desmin (Figure 7).  Our data shows nebulin 
M160-164 T5681P NM-associated mutant having an stronger binding affinity to tail (Kd 
of 63.1 nM) and to coil 2B (Kd of 34.4 nM) as compared to nebulin M160-164 L5646A 
mutant (tail Kd of 170.8 nM; coil 2B Kd of 167.1 nM).  This results indicate that each 
mutant has differential the binding properties to different parts of desmin.  
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Figure 7: ELISA saturation curves of Neb160-164 L5646A vs. Neb 160-164 T5681P with GST-tail and 
GST-coil 2B. (A) ELISA saturation curve of L5646A vs. T5681P with GST- tail. This plate illustrates the difference 
in binding for the mutants to GST-tail. It can be seen that T5681P binds stronger to GST-tail with a Kd of 63.06 and a 
Bmax of 0.6520. (B) ELISA saturation curve of L5646A vs. T5681P and GST-coil 2B. This plate shows the difference 
in binding between the two mutants to GST-coil 2B. It shows T5681P having the stronger binding with a Kd 34.4 and 




 Our data revealed that this nemaline-myopathy associated nebulin mutant bound to 
desmin GST-coil 2b region with a 5-fold decrease in affinity with respect to the WT His-
nebulin M160-164 fragment (Figure 8). In accordance to our previous saturation curve 
(Figure 6), our results show high affinity binding for coil 2B to WT nebulin M160-164 
with an estimated Kd of 34 nM (Figure 8). In contrast, the nemaline myopathy mutant 
nebulin M160-164 T5681P showed a lowered affinity binding with an estimated Kd of 




  25 
 
Figure 8: ELISA assay shows the saturation curve of desmin coil 2b and wild type nebulin M160-164 as 
compared to desmin coil 2b + nebulin M160-164 T5646P.  The nebulin fragments were plated at a 
concentration of 50nM on the microtiter plate and tested for binding with desmin coil 2B at different concentrations. 
The graph shows that desmin coil 2b binds to nebulin M160-164 with an estimated dissociation constant (Kd ) of 
34nM and a binding capacity (Bmax) of 3.942.  In contrast, our results show that desmin coil 2b binds to the nebulin 
M160-164 T5681P mutant with a Kd of 249.1 and a Bmax of 4.549.  
 
 
Desmin tail region exhibits low affinity binding to Neb M160-164 T5681P  
Ongoing experiments aim to determine the dissociation constants for the interaction of 




Figure 9: ELISA saturation curve assay illustrating GST-tail binding to WT and T5681P. This saturation 
curve shows the binding profile differences to tail for WT and T5681P. The estimated Kd values for T5681P to tail is 
738.5 nM and for WT to tail it is 12.1 nM . These values show the WT having a higher binding affinity for desmin tail 
as compared to nebulin M160-164 T5681P. 
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Further research will likely show that T5681P nebulin M160-164 mutant alters the 
binding of nebulin to desmin in muscle sarcomeres causing significant effect on actin 
regulation, we predict that this knowledge may help explain the molecular causes some 
of a number of clinical symptoms problems seen in nemaline myopathy patient cases. 
 
Nebulin M177-181 binds to GST-tail and GST-coil 2B domains of desmin 
We know from previous research that nebulin M160-164 fragment binds to the GST-coil 
1B domain of desmin (Conover et al., 2009). We wanted to test if other modules closer 
to the C-terminal of nebulin near the Z-disc in the sarcomere also had the capacity to 
bind to particular desmin fragments.  Both ELISA endpoint and saturation assays 
determined that nebulin M177-181 binds to GST- tail and GST-coil 2B regions of 
desmin (Figure 10).  Moreover, our results show that the binding of WT nebulin M177-
181 to the tail region of desmin is stronger than the binding for M160-164 WT; this can 
be seen in figure 10.  
 
 
Figure 10: ELISA saturation curve of GST-coil 2B Vs. GST-tail with His-tagged nebulin 177-181 and His- 
nebulin 160-164. These graphs illustrate the difference in binding affinity (Kd) and capacity (Bmax) of WT nebulin 
177-181 and WT nebulin 160-164 WT to desmin GST-coil 2B and desmin GST-tail. (A) The binding capacity of the 
nebulin WT module 177-181 to coil 2B and tail. Nebulin M177-181 binds with high affinity to tail (Kd is 2.538) as 
compared to desmin coil 2B with a Kd of 12.13. (B) The opposite trend is seen in the graph showing the binding of 
WT nebulin M160-164 to desmin GST-coil 2B (Kd is 29.55) and GST-tail (Kd is 57.71).  This experiment is courtesy 
of Samaneh Karami. 
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To validate our results we ran a Saturation Curve ELISA to ensure that the Desmin 
proteins where binding to the nebulin fragments and not the GST. The ELISA was set up 
with the nebulin fragments and coated with GST-alone as the secondary protein. The 
absorbance values from this ELISA (Figure 11) ensured us that GST is not the cause for 
the binding seen in earlier ELISAs. 
 
 
Figure 11: ELISA saturation curves of Neb 160-164 WT vs. L5646A & T5681P with GST-Alone. The 
ELISA graphs demonstrate the effect of GST-Alone on binding to Nebulin fragments. The Kd values determined for 
binding between Nebulin fragments and GST-Alone are very small and insignificant when compared with Kd values 
from GST-Desmin ELISAs. (A) GST-Alone shows no significant binding for neb 160-164 WT and L5646A; the Kd 
for L5646A is 0.141, for WT it is 0.07559. (B) There is no significant binding seen between GST-Alone and Neb 160-
164 T5681P; the Kd value is 0.2057 for T5681P and 0.03439 for WT.  
A B 
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CHAPTER IV 
 
SUMMARY AND CONCLUSIONS 
 
Discussion  
Mutations in six different genes have been found to cause nemaline myopathy (NM) in 
humans, a non-dystrophic myopathy. The majority of mutations are thought to occur in 
nebulin, while other genetic causes for NM include mutations other sarcomere proteins 
such as tropomyosin-3 (NEM1), alpha-actin-1 (NEM3), beta-tropomyosin (NEM4), 
troponin T1 (NEM5), and cofilin-2 (NEM7). The chromosome site for NEM6 has been 
mapped but no genetic locus has been identified to be linked to the disease.  Historically, 
the large size of nebulin protein has hindered the search for NM causative mutations 
within the nebulin gene (Pelin et al., 1999).  
 
Recent functional studies in a NM case caused by a small deletion in nebulin exon 55 
have shown that muscle weakness may result from deregulated thin filament as this 
muscle exhibits reduction of 60% force generation (Ottenheijm et al., 2009). However, 
little is known of the contribution of the intermediate filament system to the force 
generation activity of the sarcomere.  Since previous research initially showed that the 
giant nebulin protein bound to desmin by yeast-two hybrid analysis (Bang et al., 2002) 
and other data established that WT nebulin M160-164 had a high binding affinity for the 
desmin coil 1B region (Conover et al., 2009), we reason that given the importance of 
desmin to the force generation ability of muscle, if we found alterations of binding 
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between these molecules in NM it may provide for elucidating the functional basis of 
muscle weakness in NM. Thus, for this Thesis research, we focused our investigation on 
the nemaline-associated mutation T5681P to test whether our hypothesis was correct and 
elucidate how a known NM mutation (Pelin et al., 2002) would affect binding to desmin. 
We know that nebulin binds to desmin at M160-164 to desmin coil 1B, thus we choose a 
mutation within M160-164 region to characterize the potential binding difference 
profiles between the WT and the mutant.   
 
Interestingly, this particular nebulin mutation T5681P was found in two affected 
children in one Finnish family and in a single patient from another Finnish family. This 
study was done in 2002, with 77 individual patients with various forms of nemaline 
myopathy. The clinical symptoms observed in the patients with the T5681P mutation 
varied between typical (one sibling and the single patient) and intermediate (the other 
sibling) forms. Typical symptoms include moderate muscle weakness in face, trunk and 
limb muscles. Intermediate symptoms are more severe. The mutation is a missense 
mutation in exon 160 which changes threonine to proline (T5681P) (Pelin et al., 2002). 
Based on these clinical findings we proposed a hypothesis that mutations in the C-
terminal part of the nebulin gene near the Z-disc associated with NM could result from 
alterations in binding of nebulin (or potentially other nebulin family members) to the 
desmin.  
 
  30 
In our research we also studied a random alanine exchange mutation, M160-164 
L5646A, to compare our binding results to a non-pathogenic mutation within the same 
region that the nemaline-myopathy mutation, and better understand the specific effects 
caused by the disease-associated nebulin T5681P mutation.  Interestingly, the L5646A 
mutation is more N-terminally located compared to T5681P (35 residues).  Our results 
show differential binding between nebulin M160-164 L5646A and the T5681P mutant 
since we observed a lower binding of the non-pathogenic control mutant to desmin coil 
2B (Figure 7).  
 
Nebulin M177-181 binds to desmin tail region 
To gain further insight on the type of residues present in nebulin modules that are critical 
for the interaction of nebulin and desmin, we tested whether other more C-terminal 
modules M177-181 from modules M160-164 were involved in the interaction with 
desmin.  Motivated by previous yeast-two hybrids studies that showed positive 
interaction of a nebulin M160-183 with full-length desmin but that lacked the variably 
spliced modules M177-181 from psoas muscle (Bang et al., 2002), we tested whether 
these modules would contained type of residues required for a productive interaction.  
Contrary to expected results, our results showed that nebulin M177-181 does bind to 
desmin at the tail region. It also appears to bind to the coil 2B region, but not as strongly 
as M160-164 (Figure 10). These results suggest that multiple binding sites for desmin 
are present within nebulin C-terminal end that have differential binding affinities.  The 
significance of these findings warrants further investigation. 
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Desmin coil 2B and coil 1B regions exhibit binding to nebulin mutant L5646A 
Our results revealed that a random alanine substitution mutant nebulin M160-164 
L5646A binds to desmin coil 1B and coil 2B regions with a lower binding affinity than 
to WT nebulin M160-164.  This allowed us to have a base reading for future testing with 
nemaline- associated nebulin M160-164 T5681P mutant. 
 
 Our results also revealed that nebulin M160-164 T5681P mutant binds with 
significantly lowered binding affinity (~14 fold lower) than random nebulin M160-164 
L5646A to desmin’s coil 2B (~10 fold lower) as compared to wild-type nebulin M160-
164  (Fig 6 and 8). The lowered binding affinity may indicate a weaker association 
between desmin coil 2B region and mutant T5681P within cells preventing/ modifying 
normal sarcomere contraction. This weakening may aid in explaining the clinical 
symptoms observed in muscle from patients carrying the recessive T5681P missense 
mutation seen at exon 160 in the nebulin protein (Pelin et al., 2002).  
 
Nebulin mutant M160-164 T5681P binds to desmin coil 2B and tail regions 
Our ELISA saturation curves analysis show that nebulin M160-164 T5681P NM-
associated mutant binds with a higher binding affinity to desmin coil 2B (~5 fold higher) 
and tail (~3 fold higher) domains as compared to nebulin L5646A mutant (Figure 7). 
The tail domain of desmin is the non α-helical carboxyl-terminal end of desmin. Recent 
research has shown that the tail region is important in setting up the mechanical filament 
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properties of desmin (Bar et al.,2010). Our data reveals that nebulin M160-164 T5681P 
has a different alternative binding site to desmin at its tail region which it binds with low 
affinity (738.5 nM) in contrast to what was found for WT nebulin M160-164 (Fig 9).  
These results show that mutant T5681P has a dramatic impact on desmin domains than 
the mutant nebulin M160-164 L5646A, which may cause decoupling of thin filament 
system from the intermediate filament network. This finding supports our hypothesis 
that NM associated nebulin mutations can alter the binding of nebulin to desmin in vitro.  
 
Outlook and future research directions 
We proposed that the association of desmin intermediate filament network to the 
sarcomere plays a pivotal role in nemaline myopathy caused by nebulin mutations.  In 
this work, we showed by two independent biochemical approaches that the interaction of 
desmin with nebulin is not restricted to one binding sites but rather is complex and 
occurs via multiple regions in each molecule.  Additionally, we showed that altered 
binding affinity is displayed by nemaline-associated nebulin M160-164 T5681P mutant 
as compared to non-mutated nebulin and to a random nebulin L5646A mutant. Another 
interesting result that we obtained was finding a new binding site between desmin tail 
and nebulin at M177-181(nebulin) (Figure 10, unpublished data S. Karami and G. 
Conover). Our future experiments will continue testing and characterizing for new 
binding sites within nebulin and other nebulin family members, nebulette to desmin 
domains. Taken together, our results support our hypothesis that alteration of nebulin 
association with desmin may be responsible some of the symptoms observed in NM 
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patients.  Further investigation using in vivo animal models is warranted to further 





Figure 11: Working model of nebulin M160-164 WT and mutants and M177-181 WT binding to desmin. 
This figure illustrates the binding sites that we have identified through our research. Each WT or mutant 
has been seen to binds to two different areas of desmin. The arrows illustrate where each fragment has 
been seen to bind. It also shows the increase (+) or decrease (-) in binding as compared to the WT 
fragment at the same position. (A) This shows the sites on Desmin the M160-164 WT binds to. The (+) 
and (-) symbols show the increase or decrease in WT binding as compared to WT and coil 1B (Conover et 
al. 2009), which is the original site identified for WT and desmin to bind. (B) The model shows the 
binding sites for L5646A to desmin. (C) The last figure shows the binding sites we have found for T5681P 
to desmin. (D) This model depicts the binding between desmin and nebulin for Neb M177-181.  
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Since desmin is abundant in both skeletal and cardiac muscles, we propose that most 
likely a number of nebulin mutations associated with disease could be relevant to events 
occurring in cardiac muscle cells.  However, since nebulin is found in low levels in 
cardiac muscles (Kazmierski et al., 2003), we propose that the nebulin isoform 
nebulette, containing significant homology to the C-terminal end, and that is found in 
high levels in cardiac muscles (Moncman and Wang, 1995), may constitute the link that 
binds desmin to nebulette in cardiac muscles forming part of the intermediate filament 
continuum and transmitting lateral and longitudinal intermyofibrillar force between 
muscle cells.  
 
Desmin interacts with nebulin establishing a direct link between the interfilament 
network and sarcomeres at the Z-discs (Conover et al., 2009). This interaction between 
nebulin and desmin, and previous published results that show nebulin and nebulette have 
homologous interactions with thin filament structures, leads us to propose that the same 
interaction could be possible between nebulette and desmin in cardiac muscle. Future 
investigations aim to discover whether nebulette has a redundant or complementary role, 
in cardiac muscle, performing the basic functions of nebulin in skeletal muscle.  
Alternatively, our investigations will likely discover potential novel functions for 
nebulette in cardiac muscle. Our future studies will address these possibilities in detail.  
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